Clinical Pharmacists in General Practice
Clinical Pharmacists in General Practice
This service is designed to allocate funding to GPs for utilising a (senior) clinical pharmacist through the Clinical Pharmacists in General Practice Phase 2 programme. Find out more about this service, including the benefits and how it’s commissioned and provided.
Purpose and outline
Service relates to continuation of NHS England Clinical Pharmacist in General Practice Scheme. Details of scheme previously agreed with the General Practitioners Committee.
In July 2015, NHS England launched a pilot scheme to support clinical pharmacists working in general practice. This service is to support the remainder of practices still eligible under the scheme to claim reimbursement for the clinical pharmacists recruited through the Clinical Pharmacists in General Practice Phase 2 programme.
Benefits to GPs
These include:
– supporting patients to get the best use of their medicines and identifying medicines related issues
– expanding the general practice team, thus allowing reallocation of general practice workload
– increasing GP practice capacity to see and help more members of the pubic
– ensuring safer prescribing and improving patient safety and quality of care
– benefits to the wider healthcare system
– improvement in the clinical and cost-effective use of medicines.
For further information, please see the Service Specification.
Enquiries should be sent to england.contactus@nhs.net for the attention of the pharmacists team.
How this service is commissioned and provided
This service is commissioned by NHS England.
This is a manual service with two components:
Upfront payment
Follow up service for on-going claims
The Upfront payment is paid once only and cannot be claimed in more than one financial year.
The indicators and fees for Component 2 (on-going claims) cover a pharmacist’s employment in year one (Y1), year two (Y2) and year three (Y3) of the Programme.
The following table shows the indicators to submit for year 1 (Y1), year 2 (Y2) and year 3 (Y3) of the pharmacist’s employment:
Indicator, Description, £ Per Item of Service
CPY1001, Y1 Senior Clinical Pharmacist 1 WTE, £3000
CPY1002, Y1 Senior Clinical Pharmacist 0.1 WTE, £300
CPY1003, Y1 Senior Clinical Pharmacist 0.2 WTE, £600
CPY1004, Y1 Senior Clinical Pharmacist 0.3 WTE, £900
CPY1005, Y1 Senior Clinical Pharmacist 0.4 WTE, £1200
CPY1006, Y1 Senior Clinical Pharmacist 0.5 WTE, £1500
CPY1007, Y1 Senior Clinical Pharmacist 0.6 WTE, £1800
CPY1008, Y1 Senior Clinical Pharmacist 0.7 WTE, £2100
CPY1009, Y1 Senior Clinical Pharmacist 0.8 WTE, £2400
CPY1010, Y1 Senior Clinical Pharmacist 0.9 WTE, £2700
CPY1011, Y1 Clinical Pharmacist 1 WTE, £2416.66
CPY1012, Y1 Clinical Pharmacist 0.1 WTE, £241.66
CPY1013, Y1 Clinical Pharmacist 0.2 WTE, £483.33
CPY1014, Y1 Clinical Pharmacist 0.3 WTE, £725
CPY1015, Y1 Clinical Pharmacist 0.4 WTE, £966.66
CPY1016, Y1 Clinical Pharmacist 0.5 WTE, £1208.33
CPY1017, Y1 Clinical Pharmacist 0.6 WTE, £1450
CPY1018, Y1 Clinical Pharmacist 0.7 WTE, £1691.66
CPY1019, Y1 Clinical Pharmacist 0.8 WTE, £1933.33
CPY1020, Y1 Clinical Pharmacist 0.9 WTE, £2,174.99
CPY2021, Y2 Senior Clinical Pharmacist 1 WTE, £2000
CPY2022, Y2 Senior Clinical Pharmacist 0.1 WTE, £200
CPY2023, Y2 Senior Clinical Pharmacist 0.2 WTE, £400
CPY2024, Y2 Senior Clinical Pharmacist, 0.3 WTE, £600
CPY2025, Y2 Senior Clinical Pharmacist 0.4 WTE, £800
CPY2026, Y2 Senior Clinical Pharmacist 0.5 WTE, £1000
CPY2027, Y2 Senior Clinical Pharmacist 0.6 WTE, £1200
CPY2028, Y2 Senior Clinical Pharmacist 0.7 WTE, £1400
CPY2029, Y2 Senior Clinical Pharmacist 0.8 WTE, £1600
CPY2030, Y2 Senior Clinical Pharmacist 0.9 WTE, £1800
CPY2031, Y2 Clinical Pharmacist 1 WTE, £1666.66
CPY2032, Y2 Clinical Pharmacist 0.1 WTE, £166.66
CPY2033, Y2 Clinical Pharmacist 0.2 WTE, £333.33
CPY2034, Y2 Clinical Pharmacist 0.3 WTE, £499.99
CPY2035, Y2 Clinical Pharmacist 0.4 WTE, £666.66
CPY2036, Y2 Clinical Pharmacist 0.5 WTE, £833.33
CPY2037, Y2 Clinical Pharmacist 0.6 WTE, £999.99
CPY2038, Y2 Clinical Pharmacist 0.7 WTE, £1166.66
CPY2039, Y2 Clinical Pharmacist 0.8 WTE, £1333.32
CPY2040, Y2 Clinical Pharmacist 0.9 WTE, £1499.99
CPY3041, Y3 Senior Clinical Pharmacist 1 WTE, £1,083.33
CPY3042, Y3 Senior Clinical Pharmacist 0.1 WTE, £108.33
CPY3043, Y3 Senior Clinical Pharmacist 0.2 WTE, £216.66
CPY3044, Y3 Senior Clinical Pharmacist 0.3 WTE , £325.00
CPY3045, Y3 Senior Clinical Pharmacist 0.4 WTE , £433.33
CPY3046, Y3 Senior Clinical Pharmacist 0.5 WTE, £541.66
CPY3047, Y3 Senior Clinical Pharmacist 0.6 WTE , £650.00
CPY3048, Y3 Senior Clinical Pharmacist 0.7 WTE, £758.33
CPY3049, Y3 Senior Clinical Pharmacist 0.8 WTE, £866.66
CPY3050, Y3 Senior Clinical Pharmacist 0.9 WTE, £975.00
CPY3051, Y3 Clinical Pharmacist 1 WTE, £916.66
CPY3052, Y3 Clinical Pharmacist 0.1 WTE, £91.66
CPY3053, Y3 Clinical Pharmacist 0.2 WTE, £183.33
CPY3054, Y3 Clinical Pharmacist 0.3 WTE, £275.00
CPY3055, Y3 Clinical Pharmacist 0.4 WTE, £366.66
CPY3056, Y3 Clinical Pharmacist 0.5 WTE, £458.33
CPY3057, Y3 Clinical Pharmacist 0.6 WTE, £550.00
CPY3058, Y3 Clinical Pharmacist 0.7 WTE, £641.66
CPY3059, Y3 Clinical Pharmacist 0.8 WTE, £733.33
CPY3060, Y3 Clinical Pharmacist 0.9 WTE, £825.00
Component 1: Clinical pharmacists in general practice up front payment 2022/23
Quality service start date: 1 April 2022
Quality service end date: 31 March 2023
Payment period: Annual
Collection frequency: Manual entry programme to be provided by CQRS
Manual or automatic entry: Manual
Included in data collection: All system suppliers (TPP, INPS, Microtest and Emis)
Co-commissioning: Regional Local Office/CCG
Service type: DES
Component 2: Clinical pharmacists in general practice 2022/23
Quality service start date: 1 April 2022
Quality service end date: 31 March 2023
Payment period: Monthly
Collection frequency: Manual entry programme to be provided by CQRS
Manual or automatic entry: Manual
Included in data collection: All system suppliers (TPP, INPS, Microtest and Emis)
Co-commissioning: No
Service type: DES
Component 3: Clinical pharmacists in general practice 2022/23
Quality service start date: 1 April 2022
Quality service end date: 31 March 2023
Payment period: Monthly
Collection frequency: Manual entry programme to be provided by CQRS
Manual or automatic entry: Manual
Included in data collection: All system suppliers (TPP, INPS, Microtest and Emis)
Co-commissioning: No
Service type: DES
*to access this service on CQRS, please check that you have access to the correct service type. In CQRS, select ‘My Account’ from the top of the page to see a full list of all viewable services. If you don’t have access to this type of service, ask your user administrator to update your profile.
Service user guides
The Calculating Quality Reporting Service (CQRS) user guides describe how to participate, manually enter and declare achievement for this service.
Payment count/clinical codes
N/A
HPV Vaccination Programme
HPV completing dose (booster) vaccination programme.
Purpose and outline
HPV vaccine is routinely provided by schools. However, some students may miss the schools programme and present to their general practice for vaccination. Vaccination is to be provided opportunistically or on request if the patient has missed the schools provision.
From April 2022, those aged 15+ who start HPV vaccination course should receive two doses with a 6-month interval. This is a change from a 3-dose schedule which was previously recommended for this age group. Individuals who start the NHS HPV Vaccination programme prior to April 2022 should continue the planned 3 dose schedule. Those who commenced prior to April 2022 whose schedule is interrupted/delayed such that they had an interval of 6 months or more between their first and second dose only need a 2-dose schedule (do not require a 3rd dose). The second dose should be given six to 24 months after the first dose.
The Green Book advises that a 3-dose, schedule should be offered to individuals who are known to be HIV positive, including those on antiretroviral therapy, or who are known to be immunocompromised at the time of vaccination. The second dose should be given at least one month after the first dose and the third dose at least three months after the second dose. All three doses ideally should be given within a 12-month period. If the course is interrupted, it should be resumed but not repeated, ideally allowing the appropriate interval between the remaining doses.
How this service is commissioned and provided
This service is provided as part of the GMS/PMS contract provision.
Statement of Financial Entitlements
Information about this service
Quality service start date: 1 April 2022
Quality service end date: 31 August 2023
Payment period: Monthly
Collection frequency: Monthly
Manual or automatic entry: Manual
Included in data collection: N/A – no data extract
Co-commissioning: No
System type: Vaccination and Immunisation (V&I)
To access this service on CQRS, please check that you have access to the correct service type.
In CQRS, select ‘My Account’ from the top of the page to see a full list of all viewable services.
If you do not have access to this type of service, ask your user administrator to update your profile.
Service user guides
The Calculating Quality Reporting Service (CQRS) user guides describe how to participate, manually enter and declare achievement for this service.
Payment count/clinical codes
No business rules are published for manual services.
